Funded Health Care Startups in São Paulo
The disclosed round sizes in this São Paulo health care set show a wide spread: Bionexo raised $81M on 2021-10-15, which dwarfs the next-largest disclosed…
The disclosed round sizes in this São Paulo health care set show a wide spread: Bionexo raised $81M on 2021-10-15, which dwarfs the next-largest disclosed amounts (Mevo at $20M on 2024-09-18 and Sami at $20M on 2021-12-14). The smallest disclosed amount is $100K (Cyon Equipamentos on 2021-08-10 and Senior Concierge on 2021-07-14), creating a pronounced low-end floor alongside a single large outlier.
Rounds cluster heavily around late 2024 and 2022, with multiple entries between 2024-05-07 (Biologix) and 2024-11-06 (Central da Visão), and a second burst across early-to-mid 2022 (e.g., ISA on 2022-08-10 at $12M; Nexodata on 2021-07-08 is earlier, while the 2022 window includes Pre-Seed E-doutor Saúde on 2022-04-01 as undisclosed). Stage labeling is mixed: five of the 22 rows are “Series Unknown” (including Vetwork on 2024-09-09 at $4M and Conexa Saude on 2023-12-13 at $5M), and two rows are “undisclosed” (Pipo Saúde on 2025-01-01 and Mais Mu on 2023-11-01). The time span runs from 2020-08-01 (Closecare, $200K) through 2025-01-01 (Pipo Saúde).
Most recent rounds
22 shownRelated listings
Frequently asked
What does the largest disclosed round look like compared with other funded rounds in these São Paulo health care records?
Bionexo’s $81M round on 2021-10-15 is the clear outlier in disclosed size; the next-largest disclosed amounts are $20M (Mevo on 2024-09-18 and Sami on 2021-12-14), while most other disclosed rounds fall between $1M and $13M (for example, Livance at $13M on 2023-12-01 and ISA at $12M on 2022-08-10).
How are “undisclosed” and “Series Unknown” distributed, and does it affect comparability of deal sizes?
Two of 22 rows list “undisclosed” amounts (Pipo Saúde on 2025-01-01 and Mais Mu on 2023-11-01), and five of 22 are labeled “Series Unknown” (e.g., Vetwork on 2024-09-09 at $4M and Conexa Saude on 2023-12-13 at $5M). Because these entries omit stage precision or amounts, comparisons based only on disclosed $ figures can overweight named amounts like Bionexo’s $81M (2021-10-15) and Mevo’s $20M (2024-09-18).
Which time windows concentrate the most rounds among the 22 most recent entries?
There’s a late-2024 cluster from 2024-05-07 (Biologix, $1M) through 2024-11-06 (Central da Visão, $2M), including Vetwork on 2024-09-09 at $4M and Mevo on 2024-09-18 at $20M. A second dense period appears in 2022, spanning at least 2022-03-11 (Intuitive Care, $1M) to 2022-08-10 (ISA, $12M).
Is there evidence that early-stage rounds dominate the list, or do larger rounds show up across stages?
Disclosed early-stage/seed-like entries include Cyon Equipamentos (Angel, $100K on 2021-08-10), Senior Concierge (Seed, $100K on 2021-07-14), and Kompa Saúde (Seed, $2M on 2021-08-11), but large disclosed checks also appear outside those labels, including Bionexo’s $81M (Private Equity on 2021-10-15) and Mevo’s $20M (Series B on 2024-09-18).
Are there notable low-end outliers or floor effects in disclosed amounts?
The smallest disclosed amounts are $100K, appearing at least twice (Cyon Equipamentos on 2021-08-10 and Senior Concierge on 2021-07-14), while the list otherwise includes several mid-range disclosed rounds such as $1M (Biologix on 2024-05-07 and Intuitive Care on 2022-03-11) and $2M (Central da Visão on 2024-11-06 and Kompa Saúde on 2021-08-11). The overall distribution is therefore anchored by multiple $1M–$2M deals, with Bionexo’s $81M separating as a high-side outlier.
Know which startups just got funded. Every week.
Fresh funding rounds, new companies, and the sectors moving fastest — in your inbox every Monday morning.
Free. Sent every Monday. Unsubscribe anytime.